What Is Rx/Dx, and What Does It Mean to Patients?
While most companies rely on outside labs for their cancer testing (also called cancer diagnostics), Ignyta was actually founded as a molecular diagnostic company, committed to precision targeting of chronic disease. For cancer patients, the combination of precision medicines (Rx) and in-house diagnostics (Dx) means:
- A seamless end-to-end process for finding, testing, and providing targeted investigational therapies to patients with certain hard-to-treat types of cancer
- Less time and less red-tape from our first conversation to your first day in one of our clinical trials
- Our drug candidates are designed to act rapidly. Most patients who have experienced tumor shrinkage on entrectinib have done so within the first four to eight weeks
For cancer patients it can mean the difference between weeks or months spent dealing with the side-effects of chemotherapy, and getting back to the activities and people they love—For more on the people whose lives have been changed by precision medicine, see our Patient Stories page.